Your browser doesn't support javascript.
loading
[Retracted] miR­222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma.
Liu, Kai; Liu, Songyang; Zhang, Wei; Ji, Bai; Wang, Yingchao; Liu, Yahui.
Affiliation
  • Liu K; Department of Hepatopancreatobiliary Surgery, The First Hospital, Jilin University, Changchun, Jilin Province, P.R. China.
  • Liu S; Department of Hepatopancreatobiliary Surgery, The First Hospital, Jilin University, Changchun, Jilin Province, P.R. China.
  • Zhang W; Department of Hepatopancreatobiliary Surgery, The First Hospital, Jilin University, Changchun, Jilin Province, P.R. China.
  • Ji B; Department of Hepatopancreatobiliary Surgery, The First Hospital, Jilin University, Changchun, Jilin Province, P.R. China.
  • Wang Y; Department of Hepatopancreatobiliary Surgery, The First Hospital, Jilin University, Changchun, Jilin Province, P.R. China.
  • Liu Y; Department of Hepatopancreatobiliary Surgery, The First Hospital, Jilin University, Changchun, Jilin Province, P.R. China.
Int J Oncol ; 59(6)2021 Dec.
Article in En | MEDLINE | ID: mdl-34726253
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Int J Oncol Journal subject: NEOPLASIAS Year: 2021 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Int J Oncol Journal subject: NEOPLASIAS Year: 2021 Document type: Article Country of publication: